Nouress FDA Approval History
Last updated by Judith Stewart, BPharm on April 25, 2020.
FDA Approved: Yes (First approved December 13, 2019)
Brand name: Nouress
Generic name: cysteine hydrochloride
Dosage form: Injection
Company: Avadel Pharmaceuticals plc
Treatment for: Total Parenteral Nutrition
Nouress (cysteine hydrochloride) is a sulfur-containing amino acid indicated for use as an additive to amino acid solutions to meet nutritional requirements of neonates requiring total parenteral nutrition.
Development Timeline for Nouress
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.